Palisade Bio, Inc. (PALI) stock
PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.94−0.07 (-6.72%)
Close on Nov 18, 2026Market cap $164.18MP/E –Yield –
Palisade Bio revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Palisade Bio's revenue for the twelve months ending Jun 30, 2026 was $500.00K. For fiscal 2025 it was $0. The highest annual figure on record is $733.44K in fiscal 2010.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | – |
| FY2024 | Dec 31, 2024 | $0 | -100.0% |
| FY2023 | Dec 31, 2023 | $250.00K | – |
| FY2022 | Dec 31, 2022 | $0 | -100.0% |
| FY2020 | Dec 31, 2020 | $13.52K | -12.2% |
| FY2019 | Dec 31, 2019 | $15.39K | -94.1% |
| FY2018 | Dec 31, 2018 | $260.00K | 0.0% |
| FY2017 | Dec 31, 2017 | $260.00K | +1500.4% |
| FY2016 | Dec 31, 2016 | $16.25K | +56.0% |
| FY2015 | Dec 31, 2015 | $10.42K | -44.7% |
| FY2014 | Dec 31, 2014 | $18.83K | -82.9% |
| FY2013 | Dec 31, 2013 | $110.00K | -73.0% |
| FY2012 | Dec 31, 2012 | $407.71K | +4.4% |
| FY2011 | Dec 31, 2011 | $390.63K | -46.7% |
| FY2010 | Dec 31, 2010 | $733.44K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $500.00K | – |
| Q1 FY2026 | Mar 31, 2026 | $0 | – |
| Q4 FY2025 | Dec 31, 2025 | $0 | – |
| Q3 FY2025 | Sep 30, 2025 | $0 | – |
| Q2 FY2025 | Jun 30, 2025 | $0 | – |
| Q1 FY2025 | Mar 31, 2025 | $0 | – |
| Q4 FY2024 | Dec 31, 2024 | $0 | – |
| Q3 FY2024 | Sep 30, 2024 | $0 | – |
| Q2 FY2024 | Jun 30, 2024 | $0 | – |
| Q1 FY2024 | Mar 31, 2024 | $0 | -100.0% |
| Q4 FY2023 | Dec 31, 2023 | $0 | – |
| Q3 FY2023 | Sep 30, 2023 | $0 | – |
| Q2 FY2023 | Jun 30, 2023 | $0 | – |
| Q1 FY2023 | Mar 31, 2023 | $250.00K | – |
| Q4 FY2022 | Dec 31, 2022 | $0 | -100.0% |
| Q3 FY2022 | Sep 30, 2022 | $0 | -100.0% |
| Q2 FY2022 | Jun 30, 2022 | $0 | -100.0% |
| Q1 FY2022 | Mar 31, 2022 | $0 | -100.0% |
| Q4 FY2020 | Dec 31, 2020 | $2.50K | 0.0% |
| Q3 FY2020 | Sep 30, 2020 | $2.50K | 0.0% |
| Q2 FY2020 | Jun 30, 2020 | $2.50K | -68.3% |
| Q1 FY2020 | Mar 31, 2020 | $6.02K | +140.8% |
| Q4 FY2019 | Dec 31, 2019 | $2.50K | 0.0% |
| Q3 FY2019 | Sep 30, 2019 | $2.50K | 0.0% |
| Q2 FY2019 | Jun 30, 2019 | $7.89K | -96.9% |
| Q1 FY2019 | Mar 31, 2019 | $2.50K | 0.0% |
| Q4 FY2018 | Dec 31, 2018 | $2.50K | -99.0% |
| Q3 FY2018 | Sep 30, 2018 | $2.50K | 0.0% |
| Q2 FY2018 | Jun 30, 2018 | $252.50K | +10000.0% |
| Q1 FY2018 | Mar 31, 2018 | $2.50K | 0.0% |
| Q4 FY2017 | Dec 31, 2017 | $252.50K | +2787.0% |
| Q3 FY2017 | Sep 30, 2017 | $2.50K | 0.0% |
| Q2 FY2017 | Jun 30, 2017 | $2.50K | – |
| Q1 FY2017 | Mar 31, 2017 | $2.50K | – |
| Q4 FY2016 | Dec 31, 2016 | $8.75K | – |
| Q3 FY2016 | Sep 30, 2016 | $2.50K | – |
See a number that looks wrong?